Sinomune Pharmaceutical Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Holding, Subsidiary
- Established
- 1999-03-11
- Employees
- -
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
Phase 3
Completed
- Conditions
- ESRDHyperphosphatemiaEnd Stage Renal Disease
- Interventions
- Drug: Ferric citrate tablet
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Sinomune Pharmaceutical Co., Ltd
- Target Recruit Count
- 239
- Registration Number
- NCT04456803
- Locations
- 🇨🇳
The first affiliated hospital of Baotou medical college, Baotou, China
🇨🇳Beijing Tongren Hospital, Beijing, China
🇨🇳Peking Union Medical College Hospital, Beijing, China
News
No news found